Toni Foley

414 total citations
8 papers, 50 citations indexed

About

Toni Foley is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Toni Foley has authored 8 papers receiving a total of 50 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Toni Foley's work include CAR-T cell therapy research (7 papers), Advancements in Semiconductor Devices and Circuit Design (1 paper) and Acute Myeloid Leukemia Research (1 paper). Toni Foley is often cited by papers focused on CAR-T cell therapy research (7 papers), Advancements in Semiconductor Devices and Circuit Design (1 paper) and Acute Myeloid Leukemia Research (1 paper). Toni Foley collaborates with scholars based in United States. Toni Foley's co-authors include Nirali N. Shah, Bonnie Yates, John A. Ligon, Sara Silbert, Lauren Little, Lekha Mikkilineni, Daniel W. Lee, James N. Kochenderfer, Seth M. Steinberg and Jennifer N. Brudno and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Toni Foley

5 papers receiving 50 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toni Foley United States 3 40 13 13 11 7 8 50
Amy Moskop United States 6 58 1.4× 13 1.0× 8 0.6× 10 0.9× 17 2.4× 22 65
Shuixiu Peng China 2 46 1.1× 10 0.8× 10 0.8× 2 0.2× 15 2.1× 3 51
Zhuqing Xiong China 2 26 0.7× 4 0.3× 18 1.4× 5 0.5× 18 2.6× 2 51
Tiarlan Sirait France 4 30 0.8× 3 0.2× 6 0.5× 6 0.5× 10 1.4× 6 43
Elisabeth Wallhult Sweden 4 23 0.6× 6 0.5× 28 2.2× 3 0.3× 8 1.1× 7 63
Maria Almena-Carrasco France 3 36 0.9× 3 0.2× 8 0.6× 8 0.7× 17 2.4× 3 36
Khushnuma Mullanfiroze India 3 31 0.8× 3 0.2× 3 0.2× 7 0.6× 11 1.6× 10 40
Orla Stewart United Kingdom 4 31 0.8× 4 0.3× 2 0.2× 5 0.5× 8 1.1× 6 39
Riley Ennis United States 4 14 0.3× 5 0.4× 9 0.7× 2 0.2× 12 1.7× 6 54
Lisa Frölich Germany 2 27 0.7× 1 0.1× 10 0.8× 4 0.4× 6 0.9× 6 31

Countries citing papers authored by Toni Foley

Since Specialization
Citations

This map shows the geographic impact of Toni Foley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toni Foley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toni Foley more than expected).

Fields of papers citing papers by Toni Foley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toni Foley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toni Foley. The network helps show where Toni Foley may publish in the future.

Co-authorship network of co-authors of Toni Foley

This figure shows the co-authorship network connecting the top 25 collaborators of Toni Foley. A scholar is included among the top collaborators of Toni Foley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toni Foley. Toni Foley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dreyzin, Alexandra, Bonnie Yates, Haneen Shalabi, et al.. (2025). Ten-year experience of CD22 CAR T cells for children and young adults with B-cell acute lymphoblastic leukemia. Blood Advances. 10(5). 1700–1712.
2.
Silbert, Sara, Brynn B. Duncan, Bonnie Yates, et al.. (2025). Quadriparesis after CD19 × CD22 bicistronic chimeric antigen receptor T cells for B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 207(4). 1673–1678.
3.
Ligon, John A., Margaret Cupit-Link, Christine Yu, et al.. (2024). Pediatric Cancer Immunotherapy and Potential for Impact on Fertility: A Need for Evidence-Based Guidance. Transplantation and Cellular Therapy. 30(8). 737–749. 1 indexed citations
4.
Duncan, Brynn B., Sara Silbert, Bonnie Yates, et al.. (2024). Initial Experience with CD19/CD22 BiCistronic CAR T-Cells in Children and Young Adults with Recurrent or Refractory B-Cell Malignancies. Blood. 144(Supplement 1). 680–680.
5.
Silbert, Sara, Sanna Madan, Seth M. Steinberg, et al.. (2023). A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials. Blood Advances. 7(18). 5566–5578. 2 indexed citations
6.
Ligon, John A., Jacqueline Y. Maher, Toni Foley, et al.. (2022). Fertility and CAR T-cells: Current practice and future directions. Transplantation and Cellular Therapy. 28(9). 605.e1–605.e8. 20 indexed citations
7.
Ligon, John A., Seth M. Steinberg, Toni Foley, et al.. (2022). The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes. Blood Advances. 6(23). 6040–6050. 25 indexed citations
8.
Yates, Bonnie, Sara Silbert, Toni Foley, et al.. (2022). CAR T-cells effective for post-CART relapse: A new treatment paradigm.. Journal of Clinical Oncology. 40(16_suppl). e19508–e19508. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026